Primary ovarian insufficiency in the adolescent

Area of Science:

• Reproductive Endocrinology
• Pediatric Gynecology
• Adolescent Health

Background:

• Menstrual irregularities in adolescents are often overlooked or treated symptomatically without etiological investigation.
• The health implications of menstrual cycle disturbances vary significantly based on their underlying cause.
• Primary Ovarian Insufficiency (POI) is a critical diagnosis to consider in adolescent menstrual dysfunction.

Purpose of the Study:

• To emphasize the significance of early primary ovarian insufficiency (POI) diagnosis in adolescent females.
• To highlight the distinct health consequences associated with POI compared to other causes of menstrual irregularity.
• To inform clinicians about current diagnostic approaches and emerging biomarkers for POI.

Main Methods:

• Review of current literature on primary ovarian insufficiency (POI) diagnosis in adolescents.
• Discussion of diagnostic criteria, including traditional markers (gonadotropins, estradiol) and novel biomarkers (anti-Mullerian hormone).
• Outline of recommended further investigations for diagnosed POI, such as karyotyping and genetic analysis.

Main Results:

• Anti-Mullerian hormone is an emerging biomarker for POI, complementing traditional gonadotropin and estradiol measurements.
• Further evaluations including karyotype, FMR1 premutation analysis, and antibody testing are recommended upon POI diagnosis.
• Adolescents at high risk for POI, such as those undergoing cancer treatment, should be offered oocyte or ovarian tissue cryopreservation.

Conclusions:

• Primary ovarian insufficiency (POI) must be considered in the differential diagnosis of adolescent menstrual cycle irregularities.
• Timely POI diagnosis enables personalized therapeutic strategies and management of its unique health sequelae.
• Identifying premature ovarian depletion facilitates discussions regarding fertility preservation options for affected adolescents.